ProAssurance Corporation Common Stock (PRA)

NEW YORK, March 23, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ProAssurance Corporation (NYSE: PRA) to The Doctors Company. Under the terms of the proposed transaction, shareholders of ProAssurance will receive $25.00 in cash for each share of ProAssurance that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of ProAssurance Corporation (NYSE: PRA) to The Doctors Company for $25.00 in cash per share is fair to ProAssurance shareholders.

The Ademi Firm is investigating ProAssurance (NYSE: PRA) for possible breaches of fiduciary duty and other violations of law in its transaction with The Doctors Company.

The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, and ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical liability, products liability for medical technology and life sciences, and workers’ compensation insurance, today announced that they have entered into a definitive agreement under which ProAssurance will be acquired by The Doctors Company. Under the terms of the agreement, ProAssurance stockholders will receive $25.00 in cash per share, representing an approximately 60% premium to the closing price per share of ProAssurance common stock on March 18, 2025, the last trading day prior to today’s announcement, with a transaction value of approximately $1.3 billion. The combined company will have assets of approximately $12 billion.

ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability and a core small-cap value equity in the financials sector, today reported net income of $16.2 million, or $0.31 per diluted share, and operating income(1) of $18.3 million, or $0.36 per diluted share, for the three months ended December 31, 2024. For full-year 2024, ProAssurance reported net income of $52.7 million, or $1.03 per diluted share, and operating income(1) of $48.6 million, or $0.95 per diluted share.

ProAssurance Corporation (NYSE: PRA) will issue its news release and file its Form 10-K after the market closes on Monday, February 24, 2025. The release and 10-K will be available on the Company’s website at investor.proassurance.com.

HOUSTON, Jan. 24, 2025 (GLOBE NEWSWIRE) -- American National Group Inc. (the “Company”) (NYSE: ANG PRA) today announced that the Company will redeem (the “Redemption”) all the 16,000 outstanding shares of its 5.95% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series A (the “Series A Preferred Stock”) and the corresponding 16,000,000 depositary shares, each representing a 1/1,000th interest in one share of Series A Preferred Stock (the “Depositary Shares”), on February 24, 2025 (the “Redemption Date”).

PHILADELPHIA, PA / ACCESSWIRE / December 10, 2024 / The Board of Trustees of abrdn Income Credit Strategies Fund (the "Fund"), has declared a cash distribution of $0.328125 per share of the Fund's 5.250% Series A Perpetual Preferred Shares (NYSE:ACP PRA) ("Series A Preferred Shares"). The distribution is payable on December 31, 2024, to holders of Series A Preferred Shares of record on December 20, 2024 (ex-dividend date December 20, 2024).

ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability and a core small-cap value equity in the financials sector, today reported net income of $16.4 million, or $0.32 per diluted share, and operating income(1) of $17.3 million, or $0.34 per diluted share, for the three months ended September 30, 2024.

ProAssurance Corporation (NYSE: PRA) will issue its news release and file its Form 10-Q regarding third quarter 2024 results after the market closes on Thursday, November 7, 2024. The release and 10-Q will be available on the Company’s website at investor.proassurance.com.

PHILADELPHIA, PA / ACCESSWIRE / September 10, 2024 / The Board of Trustees of abrdn Income Credit Strategies Fund (the "Fund"), has declared a cash distribution of $0.328125 per share of the Fund's 5.250% Series A Perpetual Preferred Shares (NYSE:ACP PRA) ("Series A Preferred Shares"). The distribution is payable on September 30, 2024, to holders of Series A Preferred Shares of record on September 20, 2024 (ex-dividend date September 20, 2024).

ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability and a core small-cap value equity in the financials sector, today reported net income of $15.5 million, or $0.30 per diluted share, and operating income(1) of $11.5 million, or $0.23 per diluted share, for the three months ended June 30, 2024.

ProAssurance Corporation (NYSE: PRA) will issue its news release and file its Form 10-Q regarding second quarter 2024 results after the market closes on Thursday, August 8, 2024. The release and 10-Q will be available on the Company’s website at investor.proassurance.com.

PHILADELPHIA, PA / ACCESSWIRE / June 11, 2024 / The Board of Trustees of abrdn Income Credit Strategies Fund (the "Fund"), has declared a cash distribution of $0.328125 per share of the Fund's 5.250% Series A Perpetual Preferred Shares (NYSE:ACP PRA) ("Series A Preferred Shares"). The distribution is payable on July 1, 2024, to holders of Series A Preferred Shares of record on June 21, 2024 (ex-dividend date June 21, 2024).

ProAssurance Corporation (NYSE:PRA) today announced that at its Annual Meeting of Shareholders held on May 22, shareholders elected new directors Richard J. Bielen, C.P.A., and Staci M. Pierce, J.D., and re-elected directors Bruce D. Angiolillo, J.D. (chairman), and Samuel A. Di Piazza, Jr., C.P.A., to serve three year terms expiring at the company's 2027 annual meeting. The company's board of directors now consists of 10 members, down from the previous 12.

ProAssurance Corporation (NYSE: PRA) reports net income of $4.6 million, or $0.09 per diluted share, and operating income(1) of $4.2 million, or $0.08 per diluted share, for the three months ended March 31, 2024.

ProAssurance Corporation (NYSE:PRA) will report results for the quarter ended March 31, 2024 after the close of normal New York Stock Exchange trading on Monday, May 6, 2024.

ProAssurance Corporation (NYSE: PRA) reports net income of $6.4 million, or $0.12 per diluted share, and an operating loss(1) of $2.5 million, or $0.05 per diluted share, for the three months ended December 31, 2023.

ProAssurance Corporation (NYSE:PRA) will report results for the year and quarter ended December 31, 2023 after the close of normal New York Stock Exchange trading on Tuesday, February 27, 2024.

ProAssurance Corporation (NYSE: PRA) reports a net loss of $49.4 million, or $0.95 per diluted share, and an operating loss(1) of $3.7 million, or $0.07 per diluted share, for the three months ended September 30, 2023.

ProAssurance Corporation (NYSE:PRA) will report results for the quarter ended September 30, 2023 after the close of normal New York Stock Exchange trading on Wednesday, November 8, 2023.

PICA Group, part of the ProAssurance family of companies, announced today the retirement of Dr. Ross E. Taubman, DPM. effective March 31, 2024, after 12 years of dedicated service.

ProAssurance Corporation (NYSE: PRA) reports net income of $10.6 million, or $0.20 per diluted share, and operating income(1) of $8.6 million, or $0.16 per diluted share, for the three months ended June 30, 2023.